Company profile

NBE-Therapeutics LLC

BE-Therapeutics is a privately-owned Swiss biotech company based in Basel and founded in 2012 with the vision of developing next-generation immune-stimulatory antibody drug conjugate (iADCTM) products. NBE advances its products to clinical proof of concept with the goal of improving treatment options for cancer patients. The company leverages proprietary platforms covering all aspects of ADC development: its Transpo-mAb DisplayTM technology for antibody discovery, its SMAC-TechnologyTM for site-specific payload conjugation of toxins to antibodies and a novel highly effective and immune-stimulatory anthracycline-based toxin platform.

More news about NBE-Therapeutics LLC

10.12.2020 16:40

NBE Therapeutics makes a €1.18 billion exit

Please login or
register to use the
awards follow feature
28.10.2020 14:10

NBE-Therapeutics launches first clinical trials

Please login or
register to use the
awards follow feature
05.10.2020 17:15

Startups win strong and well-connected board members

Please login or
register to use the
awards follow feature
10.09.2020 16:48

NBE-Therapeutics receives USD 25 million upfront payment

Please login or
register to use the
awards follow feature
10.08.2020 11:21

An almost complete C-suite for Swiss startups

Please login or
register to use the
awards follow feature
10.01.2020 14:30

NBE-Therapeutics closes USD 22 million financing round

Please login or
register to use the
awards follow feature
07.11.2019 13:43

SOTIO expands collaboration with NBE Therapeutics

Please login or
register to use the
awards follow feature
29.10.2019 10:59

Biotech startups strengthen their teams

Please login or
register to use the
awards follow feature
28.06.2018 11:24

NOVO Holdings invests CHF 20 million in NBE Therapeutics

Please login or
register to use the
awards follow feature
03.11.2016 12:10

NBE Therapeutics Raises CHF 20 Million in Series B Funding

Please login or
register to use the
awards follow feature
01.11.2016 08:32

New partner and investor for NBE Therapeutics

Please login or
register to use the
awards follow feature
19.01.2016 10:58

Financial support for NBE-Therapeutics’ R&D project

Please login or
register to use the
awards follow feature
24.03.2015 14:29

NBE-Therapeutics closes CHF 3.0 Mio series A financing

Please login or
register to use the
awards follow feature
28.11.2014 11:30

NBE-Therapeutics obtained CHF 600K SystemsX grant

Please login or
register to use the
awards follow feature
26.02.2014 09:07

NBE-Therapeutics Announces Successful Validation of its Technology

Please login or
register to use the
awards follow feature
07.06.2013 11:30

Successful first year for NBE-Therapeutics

Please login or
register to use the
awards follow feature
31.07.2012 15:01

Ulf Grawunder starts new Life Science Company

Please login or
register to use the
awards follow feature
NBE-Therapeutics LLC

Founded
2012

Kanton
BS

Homepage

rss